China SXT Pharmaceuticals, Inc. — Investor Relations & Filings
Filings indexed
145
across all filing types
Latest filing
2026-04-09
Regulatory Filings
Country
VG
Virgin Islands (British)
Listing
US
SXTC
China SXT Pharmaceuticals, Inc. is a pharmaceutical company engaged in the research, development, manufacture, marketing, and sales of traditional Chinese medicine products. The company specializes in the production of Advanced Traditional Chinese Medicine Pieces (TCMPs), which are high-quality, precision-processed herbal medicines. Its integrated operations cover the entire product lifecycle, from initial research and development to the final sale and distribution of its products to commercial clients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B5 - China SXT Pharmaceuticals, Inc. (0001723980) (Filer) | 2026-04-09 | English | |
| 6-K - China SXT Pharmaceuticals, Inc. (0001723980) (Filer) | 2026-04-09 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-13 | English | |
| PROSPECTUS SUPPLEMENT | 2026-01-12 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-31 | English | |
| Regulatory Filings 2025 | 2025-11-17 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 33910373 | 424B5 - China SXT Pharmaceuticals, Inc. (0001723980) (Filer) | 2026-04-09 | English | ||
| 33910374 | 6-K - China SXT Pharmaceuticals, Inc. (0001723980) (Filer) | 2026-04-09 | English | ||
| 13078116 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-13 | English | ||
| 13078117 | PROSPECTUS SUPPLEMENT | 2026-01-12 | English | ||
|
2025
11 filings
| |||||
| 13078118 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-31 | English | ||
| 13078120 | Regulatory Filings 2025 | 2025-11-17 | English | ||
| 13078119 | REGISTRATION STATEMENT | 2025-11-10 | English | ||
| 13078121 | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 | 2025-11-10 | English | ||
| 13078122 | Major Shareholding Notification 2025 | 2025-08-07 | English | ||
| 13078123 | Major Shareholding Notification 2025 | 2025-08-07 | English | ||
| 13078124 | Major Shareholding Notification 2025 | 2025-08-07 | English | ||
| 13078127 | Major Shareholding Notification 2025 | 2025-08-07 | English | ||
| 13078126 | ANNUAL REPORT | 2025-07-31 | English | ||
| 13078128 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-07-29 | English | ||
| 13078129 | CURRENT REPORT | 2025-07-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
China SXT Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33830/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33830 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33830 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33830 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33830}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for China SXT Pharmaceuticals, Inc. (id: 33830)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.